ASHG 2026 has ended. This guide stays up as the record of who was there. Next: ASHG 2027, Oct 26–30, 2027 in Nashville

Centre for Addiction and Mental Health at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

Centre for Addiction and Mental Health brings 7 presentations from 3 research groups to ASHG 2026 in Montréal. Its program centres on computational and population genetics, clinical genetics, and psychiatric therapeutics. The Tanenbaum Centre for Pharmacogenetics examines CYP2D6 and CYP2C19 variation, the Tripathy Lab studies rare variants in consanguineous families, and Molecular Neuropsychiatry & Development (MiND) Lab analyses MECP2 mutations.

OrganizationASHG 2026 Attendance
2 Staff Scientists · 2 Postdocs · 2 PhD Students
Tanenbaum Centre for Pharmacogeneticscamh.ca/en/science-and-research/institutes-and-centres/tanenbaum-centre-for-pharmacogenetics
Wet + dry lab~20 people
Studies genetic, epigenetic and gene-expression data to guide psychiatric medication response. Uses IMPACT pharmacogenetic testing and large patient cohorts for personalized mental-health treatment.
72 papers since 2024
›
Genomics yields biological and phenotypic insights into bipolar disorder
Nature, 2025
Mapping the genetic landscape across 14 psychiatric disorders
Nature, 2025
Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder
Nature Genetics, 2024
Source: OpenAlex author A5056370228
Funded by Larry and Judy Tanenbaum, Government of Ontario +4 more
›
Discovery Fund · 2018
“The Discovery Fund—made possible by anonymous $100-million donation to research at CAMH in 2018—is a key driver behind these research initiatives.”
Assurex Health Ltd., CAMH-led pharmacogenetic clinical study · 2022
“Funding for the study was provided by Assurex Health Ltd. (now affiliated with Myriad Genetics), CAMH, Ontario Genomics and Genome Canada.”
Ontario Genomics, CAMH-led pharmacogenetic clinical study · 2022
“Funding for the study was provided by Assurex Health Ltd. (now affiliated with Myriad Genetics), CAMH, Ontario Genomics and Genome Canada.”
+3 more on the lab page
Source: lab pages
7 platforms and techniques
›
Works with
Pharmacogenetic testing, Genome-wide testing
Techniques
CRISPR/Cas technology, Machine learning, Genetics, epigenetics and gene-expression integration, Mitochondrial DNA biomarkers, Controlled clinical trials
Source: lab pages
No openings posted
Poster
Wed Oct 21
2:30 pm
Repeat Expansion Diseases and Psychiatric Disorders — a scoping review
Collaborators: University of Toronto, University of Colorado Anschutz +1 more
Triplet and other repeats
Poster
Wed Oct 21
2:30 pm
Poster
Thu Oct 22
4:15 pm
Integrating Immune Gene Expression and Polygenic Risk to Investigate Neuroimmune Mechanisms in Schizophrenia
Polygenic risk scorePsychiatric geneticsImmune systemBrain/nervous system
Tripathy Labtriplab.org
Dry lab~14 people
Uses single-cell RNA-sequencing, spatial transcriptomics, long-read sequencing and UK Biobank data. Develops machine-learning methods for brain cell types, neurodevelopmental disorders and psychiatric illness.
32 papers since 2024
›
Molecular architecture of human dermal sleeping nociceptors
Cell, 2026
Genetic architecture of the structural connectome
Nature Communications, 2024
Integrating single-cell and spatially resolved transcriptomic strategies to survey the astrocyte response to stroke in male mice
Nature Communications, 2024
Source: OpenAlex author A5078768179
Funded by NSERC,
›
NSERC, Discovery grant · March and April 2020
Canada's base operating grant for natural-science and engineering labs, typically five years.
“funding notices for my NSERC Discovery grant”
, NeuroNex proposal · March and April 2020
“our massive, collaborative NeuroNex proposal”
Source: lab pages
10 platforms and techniques
›
Analyzes
single-cell RNA-sequencing, spatial transcriptomics, long-read sequencing, Patch-seq, whole-cell electrophysiology, single-nucleus RNA sequencing
Techniques
machine learning, cell type deconvolution, neuron electrophysiology, neuron morphology
Source: lab pages
Currently hiring
›
“We are currently looking for Masters and PhD students.”
Source: lab positions page
Poster
Thu Oct 22
4:15 pm
Ultima Genomics whole-genome sequencing identifies candidate causative variants in consanguineous families with intellectual disability
Collaborators: Gomal University, National University of Sciences and Technology +4 more
Intellectual and developmental disabilityExome/genome sequencingSNP analysis/discoveryVariant calling
Molecular Neuropsychiatry & Development (MiND) Labvincent-lab.com
Works in rare disease.
30 papers since 2024
›
Genomics yields biological and phenotypic insights into bipolar disorder
Nature, 2025
Fine-mapping genomic loci refines bipolar disorder risk genes
Nature Neuroscience, 2025
Biallelic variants identified in 36 Pakistani families and trios with autism spectrum disorder
Scientific Reports, 2024
Source: OpenAlex author A5036637906
Poster
Wed Oct 21
2:30 pm
Expression and stability analysis of Rett Syndrome-causing MECP2 mutations.
Collaborators: University of Toronto
AutismNeurodevelopmentalProtein structureX-linked disease
1 more presenter — research group not yet identified

Explore the full ASHG 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Download the full ASHG 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Centre for Addiction and Mental Health

Tell us what you sell and we’ll find the people at Centre for Addiction and Mental Health most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction